We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...
Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.
Tezepelumab reduced the annualised asthma exacerbation rate (AAER) by 86% in a subgroup of people with severe, uncontrolled asthma and polyps in the NAVIGATOR study, topping the 41% reduction ...
The Indian government has approved a 50% increase in the ceiling prices of several essential drugs used to treat various conditions, due to increased costs and unviability issues. The National ...
By law, medical schemes are bound to pay for costs related to 271 defined diagnoses and 27 chronic diseases that qualify for prescribed minimum benefits (PMBs). The diagnoses covered under the Medical ...
AstraZeneca is adding to the thesis that the drug can cut the risk of asthma exacerbations regardless of disease severity. In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose ...
Gastroesophageal reflux disease (GERD) is a condition in which stomach acid (or other things such as bile or food) regularly travels back up through the esophagus, usually causing a sour taste and ...
Inhalers are some of the most widely used medical devices and can be lifesaving drugs for the nearly 25 million adults and children who have asthma in the United States. In asthmatics, the disease ...
An asthma attack always requires prompt treatment to prevent life-threatening complications. Treatment varies from person to person but typically includes medications that reduce airway ...
There are various causes for a subacute cough, including infections, viruses, asthma, and allergies. Symptoms of a subacute cough last 3 to 8 weeks. There can be various symptoms, depending on the ...